Cargando…
Novel CD44-downstream signaling pathways mediating breast tumor invasion
CD44, also known as homing cell adhesion molecule is a multi-structural cell molecule involved in cell-cell and cell-extracellular matrix communications. CD44 regulates a number of central signaling pathways, including PI3K/AKT, Rho GTPases and the Ras-MAPK pathways, but also acts as a growth/arrest...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231220/ https://www.ncbi.nlm.nih.gov/pubmed/30443182 http://dx.doi.org/10.7150/ijbs.23586 |
_version_ | 1783370179858661376 |
---|---|
author | Ouhtit, Allal Rizeq, Balsam Saleh, Haissam Abou Rahman, MD Mizanur Zayed, Hatem |
author_facet | Ouhtit, Allal Rizeq, Balsam Saleh, Haissam Abou Rahman, MD Mizanur Zayed, Hatem |
author_sort | Ouhtit, Allal |
collection | PubMed |
description | CD44, also known as homing cell adhesion molecule is a multi-structural cell molecule involved in cell-cell and cell-extracellular matrix communications. CD44 regulates a number of central signaling pathways, including PI3K/AKT, Rho GTPases and the Ras-MAPK pathways, but also acts as a growth/arrest sensor, and inhibitor of angiogenesis and invasion, in response to signals from the microenvironment. The function of CD44 has been very controversial since it acts as both, a suppressor and a promoter of tumor growth and progression. To address this discrepancy, we have previously established CD44-inducible system both in vitro and in vivo. Next, using microarray analysis, we have identified and validated Survivin, Cortactin and TGF-β2 as novel CD44-downstream target genes, and characterized their signaling pathways underpinning CD44-promoted breast cancer (BC) cell invasion. This report aims to update the literature by adding and discussing the impact of these novel three signaling pathways to better understand the CD44-signaling pathways involved in BC tumor cell invasion. |
format | Online Article Text |
id | pubmed-6231220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-62312202018-11-15 Novel CD44-downstream signaling pathways mediating breast tumor invasion Ouhtit, Allal Rizeq, Balsam Saleh, Haissam Abou Rahman, MD Mizanur Zayed, Hatem Int J Biol Sci Review CD44, also known as homing cell adhesion molecule is a multi-structural cell molecule involved in cell-cell and cell-extracellular matrix communications. CD44 regulates a number of central signaling pathways, including PI3K/AKT, Rho GTPases and the Ras-MAPK pathways, but also acts as a growth/arrest sensor, and inhibitor of angiogenesis and invasion, in response to signals from the microenvironment. The function of CD44 has been very controversial since it acts as both, a suppressor and a promoter of tumor growth and progression. To address this discrepancy, we have previously established CD44-inducible system both in vitro and in vivo. Next, using microarray analysis, we have identified and validated Survivin, Cortactin and TGF-β2 as novel CD44-downstream target genes, and characterized their signaling pathways underpinning CD44-promoted breast cancer (BC) cell invasion. This report aims to update the literature by adding and discussing the impact of these novel three signaling pathways to better understand the CD44-signaling pathways involved in BC tumor cell invasion. Ivyspring International Publisher 2018-10-05 /pmc/articles/PMC6231220/ /pubmed/30443182 http://dx.doi.org/10.7150/ijbs.23586 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Review Ouhtit, Allal Rizeq, Balsam Saleh, Haissam Abou Rahman, MD Mizanur Zayed, Hatem Novel CD44-downstream signaling pathways mediating breast tumor invasion |
title | Novel CD44-downstream signaling pathways mediating breast tumor invasion |
title_full | Novel CD44-downstream signaling pathways mediating breast tumor invasion |
title_fullStr | Novel CD44-downstream signaling pathways mediating breast tumor invasion |
title_full_unstemmed | Novel CD44-downstream signaling pathways mediating breast tumor invasion |
title_short | Novel CD44-downstream signaling pathways mediating breast tumor invasion |
title_sort | novel cd44-downstream signaling pathways mediating breast tumor invasion |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231220/ https://www.ncbi.nlm.nih.gov/pubmed/30443182 http://dx.doi.org/10.7150/ijbs.23586 |
work_keys_str_mv | AT ouhtitallal novelcd44downstreamsignalingpathwaysmediatingbreasttumorinvasion AT rizeqbalsam novelcd44downstreamsignalingpathwaysmediatingbreasttumorinvasion AT salehhaissamabou novelcd44downstreamsignalingpathwaysmediatingbreasttumorinvasion AT rahmanmdmizanur novelcd44downstreamsignalingpathwaysmediatingbreasttumorinvasion AT zayedhatem novelcd44downstreamsignalingpathwaysmediatingbreasttumorinvasion |